Tonix Pharmaceuticals Files 8-K
Ticker: TNXP · Form: 8-K · Filed: Apr 9, 2025 · CIK: 1430306
Sentiment: neutral
Topics: 8-K, disclosure, financials
Related Tickers: TNXP
TL;DR
TONIX files 8-K on April 9th, expect updates on Reg FD, other events, and financials.
AI Summary
Tonix Pharmaceuticals Holding Corp. filed an 8-K on April 9, 2025, reporting on events including a Regulation FD Disclosure and Other Events. The filing also includes financial statements and exhibits. The company, incorporated in Nevada, has its principal executive offices in Chatham, New Jersey.
Why It Matters
This 8-K filing provides updates on significant corporate events and financial information for Tonix Pharmaceuticals, which is crucial for investors to assess the company's current status and future prospects.
Risk Assessment
Risk Level: medium — 8-K filings can contain a wide range of information, from routine disclosures to significant events, making the risk level dependent on the specific content not fully detailed here.
Key Numbers
- 001-36019 — SEC File Number (Identifies the company's filing with the SEC.)
- 26-1434750 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Tonix Pharmaceuticals Holding Corp. (company) — Registrant
- April 9, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of Incorporation
- Chatham, New Jersey (location) — Address of principal executive offices
FAQ
What specific events are covered under the 'Regulation FD Disclosure' and 'Other Events' sections of this 8-K?
The filing indicates these sections are included, but the specific details of the events are not provided in the provided text.
What is the primary business of Tonix Pharmaceuticals Holding Corp.?
Tonix Pharmaceuticals Holding Corp. is in the Pharmaceutical Preparations industry, SIC code 2834.
When was Tonix Pharmaceuticals Holding Corp. formerly known as Tamandare Explorations Inc.?
The company changed its name from Tamandare Explorations Inc. on March 20, 2008.
What is the physical address of Tonix Pharmaceuticals' principal executive offices?
The principal executive offices are located at 26 Main Street, Suite 101, Chatham, New Jersey, 07928.
What is the telephone number for Tonix Pharmaceuticals Holding Corp.?
The registrant's telephone number, including area code, is (862) 904-8182.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2025 regarding Tonix Pharmaceuticals Holding Corp. (TNXP).